市場調査レポート - 201130
神経刺激装置：世界のパイプライン分析・競合展望および2018年までの市場予測 Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
発行
GlobalData
出版日
2012年06月30日 ページ情報
英文 Pages: 99
価格
神経刺激装置：世界のパイプライン分析・競合展望および2018年までの市場予測
Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
出版日: 2012年06月30日
ページ情報: 英文 Pages: 99
全世界の神経刺激装置の市場規模は、2011年には23億米ドル、2018年には44億米ドルに達する（2011〜2018年の年平均成長率は10％）、と予測されています。慢性痛・パーキンソン病・てんかんといった発症件数が増加している疾患での治療のため需要が、成長を促進させるものと思われます。
当レポートでは、神経刺激装置の世界市場について分析し、市場全体の構造や、総収益の実績値・予測値（2004〜2018年）、部門別・国別の詳細動向、主要企業のプロファイル、パイプライン製品、資本取引動向などの情報を盛り込んで、その結果を概略以下の構成でお届けします。
第1章 目次
第2章 イントロダクション
第3章 疾患の概要
第4章 神経刺激装置への医療費還付
脊髄刺激装置
脳深部刺激装置
仙骨神経刺激装置
迷走神経刺激装置
「人道的医療機器」(Humanitarian Use Devices)としての神経刺激装置への医療費還付
メディケア(Medicare)・メディケイド(Medicaid)サービスセンターの医療費支払い方式の変更
通院外科診療所(Ambulatory Surgical Center)の利用料金率
メディケアの外来患者向け医療費（2011年）
第5章 神経刺激装置の概要
市場の分類
脊髄刺激装置
脳深部刺激装置
仙骨神経刺激装置
迷走神経刺激装置
皮質刺激装置市場
第6章 世界市場の特徴
市場収益実績値（2004〜2011年）
市場収益予測値（2011〜2018年）
市場のダイナミクス
第7章 各国市場の分析：市場収益（2004〜2018年）
市場収益の実績値・予測値：米国（2004〜2018年）
市場収益の実績値・予測値：カナダ（2004〜2018年）
市場収益の実績値・予測値：英国（2004〜2018年）
市場収益の実績値・予測値：ドイツ（2004〜2018年）
市場収益の実績値・予測値：フランス（2004〜2018年）
市場収益の実績値・予測値：イタリア（2004〜2018年）
市場収益の実績値・予測値：スペイン（2004〜2018年）
市場収益の実績値・予測値：日本（2004〜2018年）
市場収益の実績値・予測値：中国（2004〜2018年）
市場収益の実績値・予測値：インド（2004〜2018年）
市場収益の実績値・予測値：オーストラリア（2004〜2018年）
市場収益の実績値・予測値：ブラジル（2004〜2018年）
第8章 戦略的競合企業評価
企業シェア（全世界、2011年）
Medtronic
St Jude Medical
Boston Scientific
Cyberonics
第9章 パイプライン評価
脊髄刺激装置のパイプライン製品（全7件）
脳深部刺激装置のパイプライン製品（全11件）
仙骨神経刺激装置のパイプライン製品（全3件）
迷走神経刺激装置のパイプライン製品（全4件）
皮質刺激装置市場のパイプライン製品（全1件：Cortistim）
その他のパイプライン上の神経刺激装置
第10章 取引分析
企業合併・買収（全4件）
ベンチャーキャピタル取引（全11件）
パートナーシップ取引（全3件）
第11章 付録
図表一覧
※ このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。
Abstract
Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Summary
GlobalData's new report, "Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global neurostimulation devices market. It outlines the market landscape and provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
Key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
Key segments covered are spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators and cortical stimulators.
Annualized market revenues data from 2004 to 2011, forecast to 2018, and company share data for 2011.
Qualitative analysis of key market trends, market drivers, and restraints by category within the neurostimulation devices market.
Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
Key players covered include Medtronic, St. Jude Medical, Boston Scientific Corporation and Cyberonics.
Reasons to buy
Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.
Design and develop your product development, marketing and sales strategies.
Develop market entry and market expansion strategies.
Identify key players best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
What is the next big thing in the neurostimulation devices market landscape? Identify, understand and capitalize.
Make more informed business decisions from the insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it.
TOC
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 GlobalData Report Guidance 10
3 Disease Overview 11
3.1 Chronic Pain 11
3.1.1 Types of Chronic Pain Treated with Neurostimulation 11
3.1.2 Epidemiology 12
3.1.3 Treatment 12
3.2 Parkinson's Disease 13
3.2.1 Epidemiology 13
3.2.2 Treatment 14
3.3 Epilepsy 14
3.3.1 Epidemiology 14
3.3.2 Treatment 15
4 Reimbursement for Neurostimulation Devices 16
4.1 Spinal Cord Stimulators 16
4.2 Deep Brain Stimulators 16
4.3 Sacral Nerve Stimulators 17
4.4 Vagus Nerve Stimulators 17
4.5 Reimbursement for Neurostimulators Developed as Humanitarian Use Devices 17
4.6 Centers for Medicare and Medicaid Services Payment Changes, 2011 18
4.6.1 Ambulatory Surgical Center Payment System Rates, 2011 18
4.6.2 US Medicare Hospital Outpatient Payment Rates, 2011 19
5 Device Overview - Neurostimulation Devices 20
5.1 Market Segmentation 20
5.1.1 Spinal Cord Stimulators 20
5.1.2 Deep Brain Stimulators 20
5.1.3 Sacral Nerve Stimulators 20
5.1.4 Vagus Nerve Stimulators 21
5.1.5 Cortical Stimulators 21
6 Neurostimulation Devices Market - Global Market Characterization 22
6.1 Neurostimulation Devices Market, Global, Revenue ($m), Historic, 2004-2011 22
6.2 Neurostimulation Devices Market, Global, Revenue ($m), Forecast, 2011-2018 23
6.3 Neurostimulation Devices, Market Dynamics 24
6.3.1 Market Drivers 24
6.3.2 Market Restraints 29
7 Neurostimulation Devices Market, Revenue ($m), by Country, 2004-2018 30
7.1 Neurostimulation Devices Market, The US, Revenue ($m), Historic, 2004-2011 30
7.2 Neurostimulation Devices Market, The US, Revenue ($m), Forecast, 2011-2018 31
7.3 Neurostimulation Devices Market, Canada, Revenue ($m), Historic, 2004-2011 32
7.4 Neurostimulation Devices Market, Canada, Revenue ($m), Forecast, 2011-2018 33
7.5 Neurostimulation Devices Market, The UK, Revenue ($m), Historic, 2004-2011 34
7.6 Neurostimulation Devices Market, The UK, Revenue ($m), Forecast, 2011-2018 35
7.7 Neurostimulation Devices Market, Germany, Revenue ($m), Historic, 2004-2011 36
7.8 Neurostimulation Devices Market, Germany, Revenue ($m), Forecast, 2011-2018 37
7.9 Neurostimulation Devices Market, France, Revenue ($m), Historic, 2004-2011 38
7.10 Neurostimulation Devices Market, France, Revenue ($m), Forecast, 2011-2018 39
7.11 Neurostimulation Devices Market, Italy, Revenue ($m), Historic, 2004-2011 40
7.12 Neurostimulation Devices Market, Italy, Revenue ($m), Forecast, 2011-2018 41
7.13 Neurostimulation Devices Market, Spain, Revenue ($m), Historic, 2004-2011 42
7.14 Neurostimulation Devices Market, Spain, Revenue ($m), Forecast, 2011-2018 43
7.15 Neurostimulation Devices Market, Japan, Revenue ($m), Historic, 2004-2011 44
7.16 Neurostimulation Devices Market, Japan, Revenue ($m), Forecast, 2011-2018 45
7.17 Neurostimulation Devices Market, China, Revenue ($m), Historic, 2004-2011 46
7.18 Neurostimulation Devices Market, China, Revenue ($m), Forecast, 2011-2018 47
7.19 Neurostimulation Devices Market, India, Revenue ($m), Historic, 2004-2011 48
7.20 Neurostimulation Devices Market, India, Revenue ($m), Forecast, 2011-2018 49
7.21 Neurostimulation Devices Market, Australia, Revenue ($m), Historic, 2004-2011 50
7.22 Neurostimulation Devices Market, Australia, Revenue ($m), Forecast, 2011-2018 51
7.23 Neurostimulation Devices Market, Brazil, Revenue ($m), Historic, 2004-2011 52
7.24 Neurostimulation Devices Market, Brazil, Revenue ($m), Forecast, 2011-2018 53
8 Global Neurostimulation Devices Market - Strategic Competitive Assessment 54
8.1 Neurostimulation Devices Market, Global, Company Share (%), 2011 54
8.2 Medtronic 55
8.2.1 Overview 55
8.2.2 Medtronic, Key Marketed Products 57
8.3 St Jude Medical 61
8.3.1 Overview 61
8.3.2 St Jude Medical, Marketed Products 62
8.4 Boston Scientific 64
8.4.1 Overview 64
8.4.2 Boston Scientific, Marketed Products 64
8.5 Cyberonics 65
8.5.1 Overview 65
8.5.2 Cyberonics, Key Marketed Products 65
9 Neurostimulation Devices Market - Pipeline Assessment 67
9.1 Spinal Cord Stimulators, Pipeline Products 68
9.1.1 Algostim Device 68
9.1.2 Genesis Neurostimulation System 69
9.1.3 Nevro Senza System 69
9.1.4 Next Generation Spinal Cord Stimulator System 70
9.1.5 Precision Plus Spinal Cord Stimulation System 70
9.1.6 PrimeADVANCED - Heart Failure 71
9.1.7 Subcutaneous Array of Implantable Neural Transponder System 71
9.2 Deep Brain Stimulators, Pipeline Products 72
9.2.1 Activa PC - Refractory Epilepsy 73
9.2.2 Brio Neurostimulator 73
9.2.3 Coordinated Reset-Capable Implant 74
9.2.4 Deep Brain Stimulation - Alzheimer's Disease 74
9.2.5 Deep Brain Stimulation - Mild Cognitive Impairment 75
9.2.6 Deep Brain Stimulation System - Cachexia 75
9.2.7 Deep Brain Stimulation System - Obesity 76
9.2.8 Deep Brain Stimulation System - Post-Traumatic Stress Disorder 76
9.2.9 Deep Transcranial Magnetic Stimulation System - Alzheimer's Disease 77
9.2.10 Deep Transcranial Magnetic Stimulation System - Autism 77
9.2.11 Deep Transcranial Magnetic Stimulation System - Bipolar Disorder 78
9.3 Sacral Nerve Stimulators, Pipeline Products 78
9.3.1 Sacral Nerve Stimulation Device 78
9.3.2 SAINT System - Urinary Incontinence 79
9.3.3 Verv System - Overactive Bladder 79
9.4 Vagus Nerve Stimulators, Pipeline Products 80
9.4.1 Aspire New Parameters 80
9.4.2 CardioFit System 81
9.4.3 FitNes System - Alzheimer's Disease 81
9.4.4 NEMOS - Epilepsy 82
9.5 Cortical Stimulators, Pipeline Products 82
9.6 Other Neurostimulation Devices in the Pipeline 83
10 Neurostimulation Devices Market - Deals Landscape 84
10.1 Neurostimulation Devices Market: Mergers and Acquisitions 84
10.1.1 Sorin Group Invests $7m in Enopace Biomedical 84
10.1.2 Otto Bock Healthcare Acquires Remaining 44.4% Joint Venture Stake in Neurostream Technologies from Victhom Human Bionics 84
10.1.3 Boston Scientific Sells Neurovascular Business Unit to Stryker 85
10.1.4 Vycor Medical Completes Acquisition of NovaVision 85
10.2 Global Neurostimulation Devices Market, Venture Capital Deals 86
10.2.1 Functional Neuromodulation Raises Additional $3m in Venture Financing 87
10.2.2 Nervomatrix Secures $3.5m in Series A Venture Financing 87
10.2.3 Cortec Secures $3.2m in Seed Financing 87
10.2.4 ImThera Medical Secures $4m in Series C Venture Financing 88
10.2.5 Phagenesis Secures $9.3m in Series B Venture Financing 88
10.2.6 Autonomic Technologies Secures $32m in Series C Venture Financing 88
10.2.7 SPR Therapeutics Secures $0.25m in Financing Round 88
10.2.8 Nexstim Secures Additional $2.8m in Venture Financing Round 89
10.2.9 BlueWind Medical Secures Seed Financing 89
10.2.10 Synapse Biomedical Secures $0.43m in Financing Round 89
10.2.11 EBS Technologies Secures $4.4m in Second Round of Financing 89
10.3 Global Neurostimulation Devices Market, Partnership Deals 90
10.3.1 GE Healthcare Enters into a Distribution Agreement with KC BioMedix 90
10.3.2 EndoStim Enters into an Agreement with Arizona State University 90
10.3.3 Ardiem Medical Enters into Licensing Agreement with Case Western Reserve University 91
11 Appendix 92
11.1 Definitions 92
11.1.1 Neurostimulation Devices 92
11.2 Acronyms 93
11.3 Sources 94
11.4 Research Methodology 97
11.4.1 Secondary Research 97
11.4.2 Primary Research 98
11.4.3 Models 98
11.4.4 Forecasts 98
11.4.5 Expert Panels 98
11.5 GlobalData Consulting 99
11.6 Contact Us 99
11.7 Disclaimer 99
List of Tables
1.1 List of Tables
Table 1: Ambulatory Surgical Center Medicare Payment for Spinal Cord Stimulation, 2010 vs. 2011 18
Table 2: Ambulatory Surgical Center Medicare Payment for Deep Brain Stimulation, 2010 vs. 2011 18
Table 3: Ambulatory Surgical Center Medicare Payment for Sacral Nerve Stimulation, 2010 vs. 2011 18
Table 4: Medicare Hospital Outpatient Payment for Spinal Cord Stimulation, 2010 vs. 2011 19
Table 5: Medicare Hospital Outpatient Payment for Sacral Nerve Stimulation, 2010 vs. 2011 19
Table 6: Medicare Hospital Outpatient Payment for Deep Brain Stimulation, 2010 vs. 2011 19
Table 7: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 22
Table 8: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 23
Table 9: Healthcare Costs vs. Health-related Quality of Life with Spinal Cord Stimulation and Conventional Medical Management 24
Table 10: Incremental Cost-effectiveness of Spinal Cord Stimulation Compared with Conventional Medical Management 25
Table 11: Cost Effectiveness, Post-vagus Nerve Stimulation Therapy vs. Pre-vagus Nerve Stimulation Therapy 26
Table 12: Example of Neurostimulation Products* through FDA's Fast-track Program 26
Table 13: Example of Neurostimulation Products* through FDA's Humanitarian Device Exemption Program 27
Table 14: Pipeline Products In Development for New Indications 27
Table 15: Neurostimulation Devices Market, The US, Revenue ($m), 2004-2011 30
Table 16: Neurostimulation Devices Market, The US, Revenue ($m), 2011-2018 31
Table 17: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 32
Table 18: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 33
Table 19: Neurostimulation Devices Market, The UK, Revenue ($m), 2004-2011 34
Table 20: Neurostimulation Devices Market, The UK, Revenue ($m), 2011-2018 35
Table 21: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 36
Table 22: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 37
Table 23: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 38
Table 24: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 39
Table 25: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 40
Table 26: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 41
Table 27: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 42
Table 28: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 43
Table 29: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 44
Table 30: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 45
Table 31: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 46
Table 32: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 47
Table 33: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 48
Table 34: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 49
Table 35: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 50
Table 36: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 51
Table 37: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 52
Table 38: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 53
Table 39: Neurostimulation Devices Market, Global, Company Revenue ($m), 2011 54
Table 40: Medtronic, Key Marketed Products*, Neurostimulation Devices 57
Table 41: Activa RC, PC and SC Series Neurostimulator, Features and Benefits 58
Table 42: Kinetra Neurostimulator, Features and Benefits 58
Table 43: Soletra Neurostimulator, Features and Benefits 58
Table 44: Restore Series Neurostimulator, Features and Benefits 59
Table 45: PrimeAdvanced Neurostimulator, Features and Benefits 59
Table 46: Itrel 3 neurostimulator, Features and Benefits 59
Table 47: External Trialing System, Features and Benefits 60
Table 48: St Jude Medical, Key Marketed Products*, Neurostimulation Devices 62
Table 49: Libra Family of Primary Cell IPGs, Features and Benefits 62
Table 50: Eon C Primary Cell IPGs, Features and Benefits 63
Table 51: Genesis Primary Cell IPG, Features and Benefits 63
Table 52: Rechargeable IPGs, Features and Benefits 63
Table 53: Boston Scientific, Key Marketed Products*, Neurostimulation Devices 64
Table 54: Precision Plus Spinal Cord Stimulation System, Features and Benefits 64
Table 55: Cyberonics, Key Marketed Products*, Neurostimulation Devices 65
Table 56: VNS Therapy Generator, Features and Benefits 66
Table 57: Spinal Cord Stimulators, Pipeline Products 68
Table 58: Algostim Device, Product Status 68
Table 59: Genesis Neurostimulation System - Chronic Angina, Product Status 69
Table 60: Nevro Senza System, Product Status 69
Table 61: Next Generation Spinal Cord Stimulator System, Product Status 70
Table 62: Precision Plus Spinal Cord Stimulation System, Product Status 70
Table 63: PrimeAdvanced - Heart Failure, Product Status 71
Table 64: Subcutaneous Array of Implantable Neural Transponder System - Chronic Pain, Product Status 71
Table 65: Deep Brain Stimulators, Pipeline Products 72
Table 66: Activa PC - Refractory Epilepsy, Product Status 73
Table 67: Brio Neurostimulator, Product Status 73
Table 68: CR-Capable Implant, Product Status 74
Table 69: Deep Brain Stimulation - Alzheimer's Disease, Product Status 74
Table 70: Deep Brain Stimulation - Mild Cognitive Impairment, Product Status 75
Table 71: Deep Brain Stimulation - Cachexia, Product Status 75
Table 72: Deep Brain Stimulation - Obesity, Product Status 76
Table 73: Deep Brain Stimulation - Post-Traumatic Stress Disorder 76
Table 74: Deep TMS System - Alzheimer's Disease, Product Status 77
Table 75: Deep Transcranial Magnetic Stimulation System - Autism, Product Status 77
Table 76: Deep Transcranial Magnetic Stimulation System - Bipolar Disorder, Product Status 78
Table 77: Sacral Nerve Stimulators, Pipeline Products 78
Table 78: Sacral Nerve Stimulation Device, Product Status 78
Table 79: SAINT System - Urinary Incontinence, Product Status 79
Table 80: Verv System - Overactive Bladder, Product Status 79
Table 81: Vagus Nerve Stimulators, Pipeline Products 80
Table 82: Aspire NP, Product Status 80
Table 83: CardioFit System, Product Status 81
Table 84: FitNes System - Alzheimer's Disease, Product Status 81
Table 85: NEMOS - Epilepsy, Product Status 82
Table 86: Cortical Stimulators, Pipeline Products 82
Table 87: Cortistim, Product Status 82
Table 88: Other Neurostimulation Devices in the Pipeline 83
Table 89: Neurostimulation Devices Market, Mergers and Acquisitions, Global, 2010-2011 84
Table 90: Global Neurostimulation Devices Market, Venture Capital Deals 86
Table 91: Global Neurostimulation Devices Market, Partnership Deals 90
List of Figures
1.2 List of Figures
Figure 1: Neurostimulation Devices, Market Segmentation 20
Figure 2: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 22
Figure 3: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 23
Figure 4: Neurostimulation Devices, Regulatory Path for Pipeline Products, 2012 28
Figure 5: Neurostimulation Devices Market, The US, Revenue ($m), 2004-2011 30
Figure 6: Neurostimulation Devices Market, The US, Revenue ($m), 2011-2018 31
Figure 7: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 32
Figure 8: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 33
Figure 9: Neurostimulation Devices Market, The UK, Revenue ($m), 2004-2011 34
Figure 10: Neurostimulation Devices Market, The UK, Revenue ($m), 2011-2018 35
Figure 11: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 36
Figure 12: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 37
Figure 13: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 38
Figure 14: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 39
Figure 15: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 40
Figure 16: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 41
Figure 17: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 42
Figure 18: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 43
Figure 19: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 44
Figure 20: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 45
Figure 21: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 46
Figure 22: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 47
Figure 23: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 48
Figure 24: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 49
Figure 25: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 50
Figure 26: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 51
Figure 27: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 52
Figure 28: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 53
Figure 29: Neurostimulation Devices Market, Global, Company Share* (%), 2011 54
Figure 30: Global Neurostimulation Devices, Product Mapping 55
Figure 31: Neurostimulation Devices, Analysis of Pipeline Products by Clinical Stage of Development 67
「神経刺激装置：世界のパイプライン分析・競合展望および2018年までの市場予測 」は2012年06月30日にグローバルデータ より発行されました。 当レポートはPages: 99で構成され、税抜￥382,840より販売しています。
